Facial Implants Market Growth & Trends
The global facial implants market size is expected to reach USD 5.06 billion by 2030, growing at a CAGR of 8.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of facial injuries, demand for non-surgical facial rejuvenation surgery, and the introduction of technologically advanced 3D printed implants for facial reconstruction are expected to drive the industry over the forecast period. In addition, the rising initiatives in a probe to increase awareness regarding aesthetic surgery are expected to drive industry growth in the near future. For instance, The American Society of Plastic Surgeons (ASPS) supports, educates, and advocates improved patient care & work toward enhancing awareness about aesthetics in the U.S.
It also conducts periodic medical conferences, thereby educating surgeons on the latest techniques in the field of cosmetic surgery. Furthermore, the growing geriatric population and adoption of cosmetic procedures are some of the factors contributing to the growth of the market. North America was the largest regional market and was estimated at over USD 944.1 million in 2022. The region’s market position is attributed to factors, such as the increased expenditure on aesthetic procedures, high awareness about facial rejuvenation surgery, and the presence of sophisticated healthcare infrastructure.
Request a free sample copy or view report summary: Facial Implants Market Report
Report Attribute Details Market size value in 2023 — USD 2.86 billion Revenue forecast in 2030 — USD 5.06 billion Growth rate — CAGR of 8.5% from 2023 to 2030 Base year for estimation — 2022 Historical data — 2018–2021 Forecast period — 2023–2030
Facial Implants Market Report Highlights
Global industry growth is attributed to factors, such as the growing demand for minimally invasive surgery and the prevalence of target disorders
The eyelid surgery procedure segment led the market in 2022 owing to the increasing demand for blepharoplasty procedures for the treatment of puffy eyelids, excessive fats reduction & vision correction
Chin and mandibular implants dominated the product segment with a share of over 30.3% in 2022 owing to the increasing volume of reconstructive chin augmentation procedures
The injectables segment is expected to witness significant growth over the forecast period due to the growing demand for minimally invasive facial reconstruction surgeries
Comments